Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oakwood Laboratories is a specialty pharmaceutical company and CDMO focused on the development and manufacture of sustained-release injectable drugs. The company utilizes its proprietary Chroniject™ technology, a polymer-based microsphere platform, to provide controlled delivery of therapeutic agents over periods ranging from weeks to months. Oakwood offers a full suite of services including formulation development, analytical testing, and aseptic GMP manufacturing for both internal products and partner programs. Their pipeline includes long-acting formulations of peptides and small molecules for indications such as oncology, endocrinology, and psychiatry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oakwood Healthcare.